Paul Sampognaro is a Neurology physician affiliated with University of California, San Francisco. OpenAlex indexes 24 publications with 208 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- TDP43 Degradation by the Lysosomal Proteases in Amyotrophic Lateral Sclerosis
University of California, San Francisco
FY2026$224,370K08NS121519 - TDP43 Degradation by the Lysosomal Proteases in Amyotrophic Lateral Sclerosis
University of California, San Francisco
FY2025$224,370K08NS121519 - TDP43 Degradation by the Lysosomal Proteases in Amyotrophic Lateral Sclerosis
University of California, San Francisco
FY2024$224,370K08NS121519
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”